How do you get approved for tms therapy?

To be eligible for treatment of deep EMT, a person fighting a mental health condition must meet the requirements defined by their insurance provider, which are informed by the FDA's specific authorizations for deep EMT. In many cases, insurance providers apply an additional definition to these FDA approvals. Antidepressant medications and psychotherapy are first-line treatments for major depression. However, these treatments don't work for all patients.

In these cases, TMS could be used as an alternative treatment or to increase antidepressant medications or psychotherapy. Patients who have not achieved an adequate response to antidepressants, or who are unable to tolerate medications, may consider RTMS therapy. This treatment for depression involves the administration of repetitive magnetic pulses, which is why it is called EMT or repetitive EMT. EMT is an FDA-approved treatment technique for those struggling with major depressive disorder (MDD).

One machine uses targeted magnetic pulses to stimulate the prefrontal cortex region of the brain, which is underactive in patients suffering from depression. More moderate than other options, the risk of side effects from the use of EMT is lower than with electroconvulsive therapy (ECT) and pharmacotherapy.

MagVenture TMS therapy

can be used as an adjunct therapy to other treatments for OCD. And unlike electroconvulsive therapy (ECT), RTMS doesn't cause seizures or require sedation with anesthesia.

If your insurance company denies coverage for TMS, or if you are interested in trying TMS for a condition other than MDD, there are several medical financing programs available to make treatment accessible. Patients with any type of non-removable metal on the head (with the exception of braces or dental fillings) should not receive RTM. The company was the first to receive FDA authorization for the 3-minute TMS Express, the shortest TMS treatment available today. In addition, although PTSD and anxiety also benefit from TMS, the FDA has not yet approved its use for these disorders.

While TMS can be used to treat conditions other than depression, such as bipolar disorder, anxiety, ADHD, migraines, chronic pain, and others, insurance policies generally only cover TMS for patients with moderate to severe major depressive disorder (MDD). In transcranial magnetic stimulation (TMS), an electromagnetic coil placed against the scalp creates a magnetic field that stimulates certain areas of the brain. Research has shown that approximately 1 in 2 patients will experience a significant reduction in depressive symptoms after using EMT, and 1 in 3 people will achieve complete remission of major depressive disorder (MDD). The EMT physician then measures the patient's motor threshold, delivering several brief pulses.

Only about 10% of patients experience painful sensations or tingling in the scalp during EMT treatments. With groundbreaking studies breaking new ground in the field of mental health, Deep TMS is very promising to receive approval statuses for additional mental health conditions around the world. The U.S. Food and Drug Administration (FDA) has approved transcranial magnetic stimulation (TMS therapy) for adjunctive treatment in adult patients with obsessive-compulsive disorder.

One of the most significant benefits of TMS is that it offers hope to these customers after what can be exhausting trials.